ArticleBMC neurology2025
Association between estimation of pulse wave velocity and all-cause mortality in critically ill patients with ischemic stroke: a retrospective cohort study and predictive model establishment based on machine learning.
Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundEstimated pulse wave velocity (ePWV) has been established as a simple yet effective tool for assessing arterial stiffness and predicting long-term cardiovascular and cerebrovascular mortality. However, the association between ePWV and poor prognosis in critically ill patients with ischemic stroke (IS) remains understudied. This study aimed to investigate the relationship between ePWV and adverse outcomes in critically ill IS patients.
methodsWe conducted a retrospective cohort study using data from the Medical Information Mart for Intensive Care IV (MIMIC-IV, version 3.0), stratified by ePWV quartiles. Our primary objective was to examine mortality rates at pivotal timeframes: 30 days, 90 days, and 1-year post-observation. Kaplan-Meier (KM) curves complemented these analyses, along with a Cox proportional hazards model, restricted cubic spline curves (RCS), and subgroup analysis, to comprehensively evaluate the association between ePWV and all-cause mortality. To model the mortality risk, four machine learning algorithms were employed, namely Logistic Regression (LR), Random Forest (RF), XGBoost, and Naive Bayes (NB). Model interpretability was improved using Shapley Additive Interpretation (SHAP) analysis, with calibration validating predictive accuracy. We comprehensively compared four machine learning algorithms (LR, RF, XGBoost, NB) against five clinical risk scores.
resultsOur analysis encompassed a cohort of 1,337 patients, with a male preponderance of 51.6%. The 30-day, 90-day, and 1-year mortality rates were 14.1%, 17.9%, and 23.4%, respectively. The RCS analysis revealed a dose-dependent increase in all-cause mortality risk with higher ePWV levels. Critically ill IS patients in the highest ePWV quartile had significantly higher mortality at all time points compared to lower quartiles. Boruta feature selection identified ePWV as a key predictor. The LR model demonstrated superior accuracy in predicting 30-day mortality, while XGBoost outperformed others for 90-day and 1-year mortality predictions.
conclusionElevated levels of the ePWV demonstrate strong prognostic value for both short- and long-term mortality in critically ill IS patients. Machine learning models incorporating ePWV outperformed traditional clinical scores, suggesting potential utility for risk stratification in acute stroke management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.